News

Filter

Current filters:

BayerSutent

1 to 9 of 25 results

Pfizer discontinues Ph III trial of Sutent in advanced liver cancer as it fails versus Bayer’s Nexavar

26-04-2010

In another setback to extend the indications of its cancer drug Sutent (sunitinib), global drug behemoth…

BayerNexavarOncologyOnyx PharmaceuticalsPfizerPharmaceuticalResearchSutent

Afinitor cleared in USA for advanced RCC

01-04-2009

Swiss drug major Novartis' Afinitor (everolimus) has been approved by the US Food and Drug Administration…

AfinitorAspirinBayerBayerDiovaneverolimusGleevecImatinib MesylateNexavarNovartisPfizerSorafenibSunitinib MalateSutentvalsartan

1 to 9 of 25 results

Back to top